Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Semaglutide injection products, primarily branded as Ozempic and Wegovy, are GLP-1 receptor agonists designed for weekly, subcutaneous, self-administered weight management and type 2 diabetes treatment. These products are typically indicated for chronic weight management alongside lifestyle changes, or glycemic control in adults.
| Strength | 1 mg |
| Usage | Once-weekly injection |
| Form | Pre-filled Pen (PFS/PFP) |
| Administration | Subcutaneous injection |
| Main Ingredients | Semaglutide (1.34mg/ml) Semaglutide |